Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Itraconazole sustained-release drop pills and preparation method thereof

A technology of itraconazole sustained-release dripping pills and itraconazole, which is applied in the direction of medical formulas, medical preparations with no active ingredients, medical preparations containing active ingredients, etc., can solve the problem of not being effective in time and production costs high, low dissolution rate and other problems, to achieve the effect of improving bioavailability, reducing production cost, and small difference in pellet weight

Inactive Publication Date: 2008-10-22
北京博智绿洲医药科技有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] "Itraconazole Injection", "Itraconazole Tablets" and "Itraconazole Capsules" with itraconazole as the main active ingredient have been approved by the health administrative department for production, but the injections are carried and administered Inconvenient, easy to cause adverse reactions, etc.; tablets and capsules have defects such as slow dissolution of active ingredients, poor absorption, frequent medication by patients, short effective time, and inability to take effect in time
[0009] Due to reasons such as preparation technology, oral preparations of most drugs, especially oral preparations of traditional Chinese medicines, have long dissolution time, low dissolution rate, poor absorption, many times of daily medication by patients, and unstable blood drug concentration after taking them. Hepatic and intestinal first-pass effect and low bioavailability, which affect the efficacy of the drug and directly affect the therapeutic effect
In addition, conventional oral dosage forms, such as tablets, capsules, granules (infusions), etc., due to the granulation process in the preparation process, will generate relatively large dust pollution, which will cause health problems to the staff to a certain extent. harm, and also cause some pollution to the environment
Although injections overcome the shortcomings of low bioavailability of conventional oral preparations, they also have the disadvantages of prone to allergic reactions, inconvenient use, and great pain for patients
Furthermore, the production process of conventional oral preparations and injections is complicated and the production cost is high, so that the cost of medication for patients is also increased, which is not conducive to improving the ability of patients to seek medical treatment, and is also not conducive to improving the overall health level of society

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Itraconazole sustained-release drop pills and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0037] The preparation method of itraconazole sustained-release dropping pills of the present invention will be further described with several groups of specific examples.

[0038] First group:

[0039] Based on a total weight of 100g, weigh 30% of the matrix PEG4000, 20% of PEG6000, 20% of stearic acid, 10% of glyceryl monostearate, and 20% of the raw material itraconazole; Stir to make it melt, add the corresponding proportion of itraconazole, stir well, and under the condition of heat preservation, drop the molten or mixed liquid medicine into the condensation column filled with simethicone oil, wherein, the temperature when heating and melting The temperature of the condensate is 55°C, the temperature of the upper part of the condensate is 30°C, and the temperature of the bottom is -2°C; take it out after forming.

[0040] The obtained product has a 2-hour cumulative release percentage of 35-55%, a 6-hour cumulative release percentage of 62-82%, a 10-hour cumulative relea...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug combination oral preparation having antifungal effect, that is, an Itraconazole sustained-release pill and a preparation method thereof; the invention aims at overcoming the defect of the present antifungal drug oral preparation and providing Itraconazole sustained-release pill which is characterized by high bioavailability, rapid effect, high drug content, less times of medicine taking, long acting time, stable blood concentration, convenient oral administration, low price and no pollution in the production, and the preparation method thereof. The Itraconazole sustained-release pill related by the invention uses Itraconazole as raw material and is prepared together with officinal carriers of hydrophilic framework material and hydrophobic framework material that are taken as substrate.

Description

technical field [0001] The invention relates to a pharmaceutical composition with antifungal effect, in particular to a sustained-release oral preparation of triazole antifungal drugs prepared from itraconazole. Background technique [0002] Itraconazole is a triazole oral antifungal drug. Its antibacterial spectrum is similar to that of ketoconazole. It has antibacterial effects on both deep fungi and superficial fungi. The mechanism of action is that it highly selectively acts on fungal cytochrome P-450 , to inactivate cytochrome P-450-dependent enzymes, resulting in the accumulation of 14 sterols, inhibiting the synthesis of ergosterol, thereby inhibiting and killing fungi. This product is more effective than ketoconazole at low concentrations, and is effective against some molds Infections (such as Aspergillus and Brachyphyllum sp.) are also effective, whereas ketoconazole is not effective against molds. This product is well absorbed after oral administration. It reache...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/22A61K47/32A61K47/34A61K31/496A61P31/10A61K47/10
Inventor 曲韵智
Owner 北京博智绿洲医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products